Cedars-Sinai Medical Center
Genetic Contributors to Ovarian Cancer Subtypes Uncovered in Integrated Genomic Study
Researchers unearthed new and known risk loci for ovarian cancer and ovarian cancer histotypes, and found new candidate causal variants and risk genes.
A novel computational approach to molecular profiling was used to analyze multiple biomarker types together, resulting in a parsimonious panel of pancreatic cancer survival markers.
Cedars-Sinai Sets Up $25M Single Cell Precision Medicine Center
The center will be established with a $25 million philanthropic gift from Alfred E. Mann Charities and will be named in honor of the late inventor.
New Bladder Cancer Molecular Classification Predicts Response to Common Immunotherapy
The new subtypes could help clinicians pick alternative therapies for patients unlikely to respond to Bacillus Calmette-Guérin treatment.
The assay combines microfluidics, gene expression, and digital PCR to provide information on whether a patient's cancer has metastasized.